Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL

Clinical trial NCT00225719 · COMPLETED

Trial details

NCT number: NCT00225719
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndromes

Start date: 2005-07-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.